Figure S2 from Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
Authors:
- Ezra Y. RosenEREzra Y. Rosen
- Melissa L. JohnsonMJMelissa L. Johnson
- Sarah E. CliffordSCSarah E. Clifford
- Romel SomwarRSRomel Somwar
- Jennifer F. KheraniJKJennifer F. Kherani
- Jieun SonJSJieun Son
- Arrien A. BertramABArrien A. Bertram
- Monika A. DavareMDMonika A. Davare
- Eric GladstoneEGEric Gladstone
- Elena V. IvanovaEIElena V. Ivanova
- Dahlia N. HenryDHDahlia N. Henry
- Elaine M. KelleyEKElaine M. Kelley
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)